Biogen's top products based on revenue 2021-2023
This statistic reveals Biogen's top products from 2021 to 2023, based on revenue. Biogen Inc. is a Massachusetts-based biotech company specializing in drugs for neurological disorders, autoimmune disorders and cancer. In 2023, one of the company's top products, Spinraza, generated revenues of around 1.74 billion U.S. dollars.